Sign In
Buy VLON
$0.400
+0 (+0%)
At Close: Jul 20, 2023
Vallon Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference
08:35am, Wednesday, 03'rd Mar 2021
PHILADELPHIA, PA, March 03, 2021 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on th
Vallon Pharmaceuticals Appoints Marella Thorell to Board of Directors
09:05am, Tuesday, 23'rd Feb 2021
- Accomplished executive leader with more than 30 years of experience in finance and operations
U.S. IPO Weekly Recap: IPO Frenzy Brings The Year's Largest Deal And Biggest Pop In A 17 IPO Week
11:23pm, Sunday, 14'th Feb 2021
The IPO frenzy continued this past week as 17 IPOs and 26 SPACs entered the public market. Headlining the week were dating app Bumble, which completed the year's largest deal so far, and Chinese cloud
Vallon Pharmaceuticals Announces Closing of Initial Public Offering
03:30pm, Friday, 12'th Feb 2021
PHILADELPHIA, PA, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals Inc. (NASDAQ: VLON) (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the
Vallon Pharmaceuticals Announces Pricing of Initial Public Offering
10:24pm, Tuesday, 09'th Feb 2021
PHILADELPHIA, PA, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs tha
